RE: Phase 1 to Phase 36 Feb 2024 17:07
4 Feb 2024 22:11
Not claiming to be a WiP character as we all know how that ended. But I do speak to an individual, and I call them an individual as a VP is one pharma is different to a VP in another. If you know, you know.
The message is that there is huge motivation and pressure to shortening the time to market, how to shorten that timeframe and take compounds from phase 1 to phase 3.
I think we all need to realise the money involved here as we move forward, Tim and John probably (hopefully) realise that. Hence the "noted" phrases they tend to use in recent tyk2 deals and approvals.
If we have good results from phase 1b, somebody tell me why we wouldn't go to a phase 3. As I have it on good information that this is what big pharma are moving towards. Patent expiration should never be overlooked, the ultimate driver for all of this is profit for the company buying the molecule. Competition can and do take a molecular structure from the patent information, add a sugar molecular and then go to market. Speed is everything and to Sareums due, they have been on time with everything since trials started.
Everyone is here to make money but the real money is not the brokers or the traders in London, it's the executives and board of the pharmas, are we on their radar.. with a trial for Psoriasis in competition with a supermajor BMS and now Takeda, don't underestimate the importance of this Phase 1b. Which we will have results for by the end of this year.
Yes, we have been hammered by multiple factors, but the potential is still there and has only got stronger.
Do you believe in the potential or not, we are close, hold the course, buy Sareum or keep buying lottery tickets. I only gamble when I know I'll win and I'm all in.